These data represent only a small sample of IDH-mutant astrocytomas with methylation profiling paired with other molecular and clinical data and as such does not necessarily define the full molecular parameters of these tumors. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).